Wegen, Simone
Weindler, Jasmin
Voltin, Conrad-Amadeus
van Heek, Lutz
Schomäcker, Klaus
Fischer, Thomas
Marnitz, Simone
Kobe, Carsten
Drzezga, Alexander
Roth, Katrin S. http://orcid.org/0000-0002-3786-2777
Funding for this research was provided by:
SOFIE
Universitätsklinikum Köln
Article History
Received: 4 April 2023
Accepted: 5 July 2023
First Online: 16 August 2023
Declarations
:
: A. Drzezga discloses research support from Siemens Healthineers, Life Molecular Imaging, GE Healthcare, AVID Radiopharmaceuticals, SOFIE and Eisai; speaker honoraria and/or advisory boards fees from Siemens Healthineers, Sanofi, GE Healthcare, Biogen, Novo Nordisk; Invicro; shareholder at Siemens Healthineers and Lantheus Holding; patent pending for 18F-PSMA7 (PSMA PET imaging tracer). S. Wegen, J. Weindler, C.-A. Voltin, L. van Heek, K. Schomäcker, T. Fischer, S. Marnitz, C. Kobe, and K.S. Roth declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.